CCR5 and HIV-1 infection: A decade ago, the “Berlin patient” with acute myeloid leukemia (AML) and HIV-1 infection accepted a bone-marrow transplant from a natural CCR5 Δ 32 mutation donor for leukemia therapy, which also blocked his HIV-1 infection without further ART [58,59].